Brickell Biotech announces launch date for sofpironium bromide 5% gel (Ecclock) in Japan by its development partner, Kaken Pharmaceutical

Brickell Biotech

18 November 2020 - Kaken plans to launch Ecclock for the treatment of primary axillary hyperhidrosis in Japan on 26 November 2020.

In addition, Ecclock has been placed today on Japan’s National Health Insurance (NHI) drug reimbursement price list. 

The NHI listed drug price for Ecclock in Japan is ¥243.70 per gram, which is ¥4,874.00 (USD $46.47) for a 20 g bottle or approximately a 2 week supply.

Read Brickell Biotech press release

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Outcome , Medicine , Japan